Alexandrite Laser segmentation by application reveals three principal categories: dermatology, cosmetic, and ophthalmology. The dermatology segment, accounting for roughly 55 % of total revenue, includes tattoo‑removal, pigmented‑lesion clearance, and hair‑reduction procedures. Its dominance stems from the laser’s 755 nm wavelength, which aligns with melanin absorption peaks, enabling efficient energy delivery and high procedure throughput. The cosmetic segment contributes about 30 % and is driven by skin‑rejuvenation, vascular‑lesion treatment, and photorejuvenation uses where precise thermal injury is required for collagen remodeling. Although the market share is smaller, growth rates exceed those of dermatology due to expanding aesthetic‑procedure demand in emerging economies. The ophthalmology segment, representing roughly 15 % of sales, is limited to laser iridotomy and certain retinal‑therapy applications where the laser’s selective photothermolysis can create controlled micro‑perforations. Each application’s regulatory pathway, reimbursement environment, and procedure volume collectively shape its share of the overall Alexandrite Laser market.